Cargando…
From actually toxic to highly specific – novel drugs against poxviruses
The potential use of variola virus, the causative agent of smallpox, as a bioweapon and the endemic presence of monkeypox virus in Africa demonstrate the need for better therapies for orthopoxvirus infections. Chemotherapeutic approaches to control viral infections have been less successful than tho...
Autores principales: | Sliva, Katja, Schnierle, Barbara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781423/ https://www.ncbi.nlm.nih.gov/pubmed/17224068 http://dx.doi.org/10.1186/1743-422X-4-8 |
Ejemplares similares
-
Selective gene silencing by viral delivery of short hairpin RNA
por: Sliva, Katja, et al.
Publicado: (2010) -
Recombinant poxvirus vaccines in biomedical research
por: Schnierle, Barbara S., et al.
Publicado: (2007) -
Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system
por: Kraus, Benjamin, et al.
Publicado: (2014) -
Vaccination directed against the human endogenous retrovirus-K envelope protein shows efficiency in a murine tumor model system
por: Kraus, Benjamin, et al.
Publicado: (2013) -
Murine leukemia virus (MLV) replication monitored with fluorescent proteins
por: Sliva, Katja, et al.
Publicado: (2004)